UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
+Added: Recent Sales of Unregistered Securities
+Added: In connection with the Company’s acquisition of Convergence Labs Ltd.
+Added: (“Convergence”), on June 11, 2025, the Company issued 57,276 shares of its common stock to certain former stockholders of Convergence that will vest over time.
+Added: These issuances were made in reliance on one or more of the following exemptions or exclusions from the registration requirements of the Securities Act:
+Added: Section 4(a)(2) of the Securities Act, Regulation D promulgated under the Securities Act and Regulation S promulgated under the Securities Act.
Issuer Purchases of Equity Securities
−Removed: Share repurchases of the Company’s common stock for the three months ended April 30, 2025 were as follows (in millions, except for average price paid per share):
+Added: Share repurchases of the Company’s common stock for the three months ended July 31, 2025 were as follows (in millions, except for average price paid per share):
Period Total Number of Shares Purchased (1) Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Program (1) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
−Removed: February 2025 2 $319.41 2 $10,034
−Removed: March 2025 3 279.46 3 9,121
−Removed: April 2025 5 253.51 5 7,888
+Added: May 2025 2 $279.48 2 $7,193
+Added: June 2025 3 266.22 3 6,479
+Added: July 2025 3 265.37 3 5,689
(1) The Board authorized the Share Repurchase Program, which commenced in August 2022 and had additional authorizations approved by the Board in February 2023 and February 2024, for an aggregate total authorization of $30.0 billion.
+Added: In September 2025, the Board authorized an additional $20.0 billion in repurchases under the Share Repurchase Program, for an aggregate total authorized of $50.0 billion.
The Share Repurchase Program does not have a fixed expiration date and does not obligate the Company to acquire any specific number of shares.
7 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.